comparemela.com

Latest Breaking News On - Apogee therapeutics daily - Page 2 : comparemela.com

Apogee Therapeutics (NASDAQ:APGE) Receives Outperform Rating from Wedbush

Wedbush reaffirmed their outperform rating on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research report sent to investors on Monday, RTT News reports. They currently have a $87.00 price target on the stock. Wedbush also issued estimates for Apogee Therapeutics’ Q2 2024 earnings at ($0.59) EPS, Q3 2024 earnings at ($0.60) EPS, […]

Bank of America Begins Coverage on Apogee Therapeutics (NASDAQ:APGE)

Bank of America Begins Coverage on Apogee Therapeutics (NASDAQ:APGE)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52 92

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52 92
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52 92

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52 92
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Apogee Therapeutics (NASDAQ:APGE) Trading Down 6 2%

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares dropped 6.2% during trading on Wednesday . The stock traded as low as $46.52 and last traded at $46.67. Approximately 102,297 shares were traded during trading, a decline of 83% from the average daily volume of 619,341 shares. The stock had previously closed at $49.77. Analyst […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.